Author + information
- Received January 10, 1990
- Revision received June 21, 1990
- Accepted July 6, 1990
- Published online January 1, 1991.
- Marlon S. Rosenbaum, MD, FACC∗,
- David J. Wilber, MD†,†,
- Dianne Finkelstein, PhD∗,
- Jeremy N. Ruskin, MD, FACC∗ and
- Hasan Garan, MD, FACC∗∗,1
- ↵∗Address for reprints: Hasan Garan, MD, Caardiac Unit, Massachusttes General Hospital, Fruit Street, Boston, Massachusetts 02114.
The immediate reproducibility of sustained ventricular tachycardia induction was evaluated prospectively during 106 studies performed in 53 patients with clinical sustained monomorphic ventricular tachycardia. Programmed electrical stimulation was performed twice, using the same protocol during 53 drug-free studies and 53 subsequent studies on antiarrhythmic therapy.
Sustained monomorphic ventricular tachycardia was reproduced in 104 (98%) of the 106 studies. There was no significant difference in the incidence of reproducible tachycardia in the drug-free state compared with that observed during treatment with different classes of antiarrhythmic drugs. An increase in the number of extrastimuli was required to reinitiate the tachycardia in 9 (11%) of 83 studies in which single or double extrastimuli were initially required to induce the tachycardia. In 39 (37%) of 104 studies with reproducible tachycardia induction, the two tachycardias significantly differed in electrocardiographic (ECG) configuration and cycle length.
These observations suggest that the overall reproducibility of ventricular tachycardia induction is sufficiently high to provide a reliable marker for evaluating the efficacy of therapeutic interventions. However, specific tachycardia characteristics such as cycle length and ECG configuration are more variable even within the same study and may be less useful in assessing the effects of subsequent interventions.
- Received January 10, 1990.
- Revision received June 21, 1990.
- Accepted July 6, 1990.